| Year |
Citation |
Score |
| 2023 |
Wahid M, Pratoomthai B, Egbuniwe IU, Evans HR, Babaei-Jadidi R, Amartey JO, Erdelyi V, Yacqub-Usman K, Jackson AM, Morris JC, Patel PM, Bates DO. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion. Cancer Immunology, Immunotherapy : Cii. PMID 37973660 DOI: 10.1007/s00262-023-03534-z |
0.768 |
|
| 2023 |
Alalwany RH, Hawtrey T, Morgan K, Morris JC, Donaldson LF, Bates DO. Vascular endothelial growth factor isoforms differentially protect neurons against neurotoxic events associated with Alzheimer's disease. Frontiers in Molecular Neuroscience. 16: 1181626. PMID 37456522 DOI: 10.3389/fnmol.2023.1181626 |
0.787 |
|
| 2023 |
Marva G, Ünsal S, Benest AV, Bates DO, Ordóñez-Morán P. Novel Approach to Measure Transepithelial Electrical Resistance in Intestinal Cells. Methods in Molecular Biology (Clifton, N.J.). 2650: 35-42. PMID 37310621 DOI: 10.1007/978-1-0716-3076-1_3 |
0.649 |
|
| 2022 |
Supradit K, Boonsri B, Duangdara J, Thitiphatphuvanon T, Suriyonplengsaeng C, Kangsamaksin T, Janvilisri T, Tohtong R, Yacqub-Usman K, Grabowska AM, Bates DO, Wongprasert K. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis. Toxicology in Vitro : An International Journal Published in Association With Bibra. 105385. PMID 35568131 DOI: 10.1016/j.tiv.2022.105385 |
0.41 |
|
| 2022 |
Da Vitoria Lobo ME, Weir N, Hardowar L, Al Ojaimi Y, Madden R, Gibson A, Bestall SM, Hirashima M, Schaffer CB, Donaldson LF, Bates DO, Hulse RP. Hypoxia induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain. Pain. PMID 35353768 DOI: 10.1097/j.pain.0000000000002627 |
0.754 |
|
| 2022 |
Malhi NK, Allen CL, Stewart E, Horton KL, Riu F, Batson J, Amoaku W, Morris JC, Arkill KP, Bates DO. Serine/arginine rich protein kinase-1 (SRPK1) inhibition for the treatment of diabetic retinopathy. American Journal of Physiology. Heart and Circulatory Physiology. PMID 35302878 DOI: 10.1152/ajpheart.00001.2022 |
0.738 |
|
| 2022 |
Green KR, Beazley-Long N, Lynch AP, Allen CL, Bates DO, Benest AV. Quantification of Angiogenesis in Laser Choroidal Neovascularization. Methods in Molecular Biology (Clifton, N.J.). 2441: 223-231. PMID 35099740 DOI: 10.1007/978-1-0716-2059-5_17 |
0.798 |
|
| 2022 |
Malhi NK, Bates DO, Arkill KP, Allen CL. Noninvasive Measurement of Retinal Microvascular Permeability During Loss of Endothelial Quiescence. Methods in Molecular Biology (Clifton, N.J.). 2441: 135-156. PMID 35099734 DOI: 10.1007/978-1-0716-2059-5_11 |
0.722 |
|
| 2021 |
Allen CL, Wolanska K, Malhi NK, Benest AV, Wood ME, Amoaku W, Torregrossa R, Whiteman M, Bates DO, Whatmore JL. Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier. Frontiers in Cell and Developmental Biology. 9: 724905. PMID 34557493 DOI: 10.3389/fcell.2021.724905 |
0.825 |
|
| 2021 |
Star E, Stevens M, Gooding C, Smith CWJ, Li L, Ayine ML, Harper SJ, Bates DO, Oltean S. A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties. Oncogenesis. 10: 36. PMID 33941763 DOI: 10.1038/s41389-021-00323-0 |
0.411 |
|
| 2020 |
Makhafola TJ, Mbele M, Yacqub-Usman K, Hendren A, Haigh DB, Blackley Z, Meyer M, Mongan NP, Bates DO, Dlamini Z. Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant, . Frontiers in Oncology. 10: 547392. PMID 33163396 DOI: 10.3389/fonc.2020.547392 |
0.78 |
|
| 2020 |
Ketelaar ME, Portelli MA, Dijk FN, Shrine N, Faiz A, Vermeulen CJ, Xu CJ, Hankinson J, Bhaker S, Henry AP, Billington CK, Shaw DE, Johnson SR, Benest AV, Pang V, ... Bates D, et al. Phenotypic and functional translation of IL33 genetics in asthma. The Journal of Allergy and Clinical Immunology. PMID 32442646 DOI: 10.1016/J.Jaci.2020.04.051 |
0.651 |
|
| 2020 |
Grant ZL, Whitehead L, Wong VHY, He Z, Yan RY, Miles AR, Benest AV, Bates DO, Prahst C, Bentley K, Bui BV, Symons RC, Coultas L. Blocking endothelial apoptosis revascularises the retina in a model of ischemic retinopathy. The Journal of Clinical Investigation. PMID 32427589 DOI: 10.1172/Jci127668 |
0.75 |
|
| 2020 |
Allen CL, Malhi NK, Whatmore JD, Bates DO, Arkill KP. Non-invasive measurement of retinal permeability in a diabetic rat model. Microcirculation (New York, N.Y. : 1994). PMID 32352608 DOI: 10.1111/Micc.12623 |
0.699 |
|
| 2020 |
Owen-Woods C, Joulia R, Barkaway A, Rolas L, Ma B, Nottebaum AF, Arkill KP, Stein M, Girbl T, Golding M, Bates DO, Vestweber D, Voisin MB, Nourshargh S. Local microvascular leakage promotes trafficking of activated neutrophils to remote organs. The Journal of Clinical Investigation. PMID 31971917 DOI: 10.1172/Jci133661 |
0.44 |
|
| 2019 |
Stevens M, Star E, Lee M, Innes E, Li L, Bowler E, Harper S, Bates DO, Oltean S. The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds . Rna Biology. 1-10. PMID 31432737 DOI: 10.1080/15476286.2019.1652522 |
0.766 |
|
| 2019 |
Machado MJC, Boardman R, Riu F, Emanueli C, Benest AV, Bates DO. Enhanced Notch signaling modulates unproductive revascularization in response to Nitric Oxide-Angiopoietin signaling in a mouse model of peripheral ischemia. Microcirculation (New York, N.Y. : 1994). e12549. PMID 30974486 DOI: 10.1111/Micc.12549 |
0.831 |
|
| 2019 |
Boardman R, Pang V, Malhi N, Lynch AP, Leach L, Benest AV, Bates DO, Machado MJ. Activation of Notch signalling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30681366 DOI: 10.1152/Ajpheart.00610.2018 |
0.847 |
|
| 2018 |
Onions K, Gamez M, Buckner NR, Baker SL, Betteridge KB, Desideri S, Dallyn BP, Ramnath R, Neal CR, Farmer LK, Mathieson PW, Gnudi L, Alitalo K, Bates DO, Salmon AHJ, et al. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. Diabetes. PMID 30389746 DOI: 10.2337/Db18-0045 |
0.838 |
|
| 2018 |
Neal CR, Arkill KP, Bell JS, Betteridge KB, Bates DO, Winlove CP, Salmon AHJ, Harper SJ. Novel hemodynamic structures in the human glomerulus. American Journal of Physiology. Renal Physiology. 315: F1370-F1384. PMID 30388047 DOI: 10.1152/ajprenal.00566.2017 |
0.793 |
|
| 2018 |
Descamps B, Saif J, Benest AV, Biglino G, Bates DO, Chamorro-Jorganes A, Emanueli C. BDNF (Brain-Derived Neurotrophic Factor) Promotes Embryonic Stem Cells Differentiation to Endothelial Cells Via a Molecular Pathway, Including MicroRNA-214, EZH2 (Enhancer of Zeste Homolog 2), and eNOS (Endothelial Nitric Oxide Synthase). Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 2117-2125. PMID 30354255 DOI: 10.1161/Atvbaha.118.311400 |
0.759 |
|
| 2018 |
Bates DO, Beazley-Long N, Benest AV, Ye X, Ved N, Hulse RP, Barratt S, Machado MJ, Donaldson LF, Harper SJ, Peiris-Pages M, Tortonese DJ, Oltean S, Foster RR. Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators. Comprehensive Physiology. 8: 955-979. PMID 29978898 DOI: 10.1002/Cphy.C170015 |
0.836 |
|
| 2018 |
Bestall SM, Hulse RP, Blackley Z, Swift M, Ved N, Paton K, Beazley-Long N, Bates DO, Donaldson LF. Sensory neuronal sensitisation occurs through HMGB-1/ RAGE and TRPV1 in high glucose conditions. Journal of Cell Science. PMID 29930087 DOI: 10.1242/Jcs.215939 |
0.785 |
|
| 2018 |
Neal CR, Arkill K, Bell JS, Betteridge KB, Bates DO, Winlove CP, Salmon AH, Harper SJ. NOVEL HAEMODYNAMIC STRUCTURES IN THE HUMAN GLOMERULUS. American Journal of Physiology. Renal Physiology. PMID 29923763 DOI: 10.1152/Ajprenal.00566.2017 |
0.798 |
|
| 2018 |
Ved N, Da Vitoria Lobo ME, Bestall SM, L Vidueira C, Beazley-Long N, Ballmer-Hofer K, Hirashima M, Bates DO, Donaldson LF, Hulse RP. Diabetes-induced microvascular complications at the level of the spinal cord; a contributing factor in diabetic neuropathic pain. The Journal of Physiology. PMID 29774557 DOI: 10.1113/Jp275067 |
0.809 |
|
| 2018 |
Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. PMID 29766399 DOI: 10.1007/S10456-018-9613-X |
0.419 |
|
| 2018 |
Beazley-Long N, Moss CE, Ashby WR, Bestall SM, Almahasneh F, Durrant AM, Benest AV, Blackley Z, Ballmer-Hofer K, Hirashima M, Hulse RP, Bates DO, Donaldson LF. VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis. Brain, Behavior, and Immunity. PMID 29548992 DOI: 10.1016/J.Bbi.2018.03.012 |
0.817 |
|
| 2018 |
Stevens M, Neal CR, Salmon AHJ, Bates DO, Harper SJ, Oltean S. Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular Injury. Nephron. PMID 29393270 DOI: 10.1159/000485664 |
0.798 |
|
| 2018 |
Barratt SL, Blythe T, Ourradi K, Jarrett C, Welsh GI, Bates DO, Millar AB. Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF). Respiratory Research. 19: 9. PMID 29334947 DOI: 10.1186/S12931-017-0711-X |
0.739 |
|
| 2017 |
Pang V, Bates DO, Leach L. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin. Clinical Science (London, England : 1979). PMID 29054861 DOI: 10.1042/Cs20171252 |
0.587 |
|
| 2017 |
Barratt SL, Blythe T, Jarrett C, Ourradi K, Shelley-Fraser G, Day MJ, Qiu Y, Harper S, Maher TM, Oltean S, Hames TJ, Scotton CJ, Welsh GI, Bates DO, Millar AB. Differential Expression of VEGF-Axxx Isoforms is Critical for Development of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 28661183 DOI: 10.1164/Rccm.201603-0568Oc |
0.761 |
|
| 2017 |
Mortara L, Benest AV, Bates DO, Noonan DM. Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours? Current Opinion in Pharmacology. 35: 66-74. PMID 28623714 DOI: 10.1016/J.Coph.2017.05.009 |
0.701 |
|
| 2017 |
Stevens M, Neal CR, Salmon AH, Bates DO, Harper SJ, Oltean S. VEGF-A165 b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney. The Journal of Physiology. PMID 28574576 DOI: 10.1113/Jp274481 |
0.852 |
|
| 2017 |
Betteridge K, Arkill K, Neal C, Harper S, Foster B, Satchell S, Bates D, Salmon A. Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function. The Journal of Physiology. PMID 28524373 DOI: 10.1113/Jp274167 |
0.848 |
|
| 2017 |
Sae-Lao T, Tohtong R, Bates DO, Wongprasert K. Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation. The American Journal of Chinese Medicine. 1-19. PMID 28385079 DOI: 10.1142/S0192415X17500367 |
0.333 |
|
| 2017 |
Ved N, Hulse RP, Bestall SM, Donaldson LF, Bainbridge JW, Bates D. Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina. Clinical Science (London, England : 1979). PMID 28341661 DOI: 10.1042/Cs20170102 |
0.855 |
|
| 2017 |
Castle-Miller J, Bates DO, Tortonese DJ. Mechanisms regulating angiogenesis underlie seasonal control of pituitary function. Proceedings of the National Academy of Sciences of the United States of America. PMID 28270617 DOI: 10.1073/Pnas.1618917114 |
0.823 |
|
| 2017 |
Batson J, Toop HD, Redondo C, Babaei-Jadidi R, Chaikuad A, Wearmouth SF, Gibbons B, Allen C, Tallant C, Zhang J, Du C, Hancox J, Hawtrey T, Da Rocha J, Griffith R, ... ... Bates DO, et al. Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease. Acs Chemical Biology. PMID 28135068 DOI: 10.1021/Acschembio.6B01048 |
0.434 |
|
| 2017 |
Bates DO, Morris JC, Oltean S, Donaldson LF. Pharmacology of Modulators of Alternative Splicing. Pharmacological Reviews. 69: 63-79. PMID 28034912 DOI: 10.1124/Pr.115.011239 |
0.736 |
|
| 2017 |
Allen C, Horton K, Malhi N, Batson J, Bates D. The SRPK1 inhibitor SPHINX31 prevents increased retinal permeability in a rodent model of diabetes Acta Ophthalmologica. 95. DOI: 10.1111/J.1755-3768.2017.0F066 |
0.75 |
|
| 2017 |
Batson J, Toop H, Daubney J, Liddell S, Stewart E, Bourne J, Blackley Z, Morris J, Bates D. Optimisation of novel small molecule inhibitors of SRPK1-mediated VEGF-A splicing through modelling of permeability properties required for trans-scleral eye drop delivery Acta Ophthalmologica. 95. DOI: 10.1111/J.1755-3768.2017.02612 |
0.793 |
|
| 2017 |
Pang V, Bates DO, Leach L. Competitive interplay between VEGF-A165a, VEGF-A165b, PLGF and VE-cadherin in the human feto-placental endothelial barrier Placenta. 57: 313. DOI: 10.1016/J.Placenta.2017.07.281 |
0.559 |
|
| 2016 |
Stone OA, Carter JG, Lin PC, Paleolog E, Machado MJ, Bates DO. Differential regulation of blood flow induced neovascularisation and mural cell recruitment by VEGF and angiopoietin signalling. The Journal of Physiology. PMID 27868196 DOI: 10.1113/Jp273430 |
0.85 |
|
| 2016 |
Hulse RP, Drake RA, Bates DO, Donaldson LF. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain. Neurobiology of Disease. PMID 27616424 DOI: 10.1016/J.Nbd.2016.09.009 |
0.757 |
|
| 2016 |
Benest AV, Bates DO. Measurement of Angiogenesis, Arteriolargenesis, and Lymphangiogenesis Phenotypes by Use of Two-Dimensional Mesenteric Angiogenesis Assay. Methods in Molecular Biology (Clifton, N.J.). 1430: 345-54. PMID 27172966 DOI: 10.1007/978-1-4939-3628-1_24 |
0.788 |
|
| 2016 |
Gammons MV, Bates DO. Models of Oxygen Induced Retinopathy in Rodents. Methods in Molecular Biology (Clifton, N.J.). 1430: 317-32. PMID 27172964 DOI: 10.1007/978-1-4939-3628-1_22 |
0.739 |
|
| 2016 |
Ye X, Abou-Rayyah Y, Bischoff J, Ritchie A, Sebire NJ, Watts P, Churchill AJ, Bates DO. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt the vascular maturation in infantile haemangioma. The Journal of Pathology. PMID 26957058 DOI: 10.1002/Path.4715 |
0.827 |
|
| 2016 |
Allen C, Bates D. In vivo measurement of increased vascular permeability after STZ induction of diabetes in rats by fluorescence angiography using the Micron IV Acta Ophthalmologica. 94. DOI: 10.1111/J.1755-3768.2016.0468 |
0.373 |
|
| 2015 |
Lobo DP, Wemyss AM, Smith DJ, Straube A, Betteridge KB, Salmon AH, Foster RR, Elhegni HE, Satchell SC, Little HA, Pacheco-Gómez R, Simmons MJ, Hicks MR, Bates DO, Rodger A, et al. Direct detection and measurement of wall shear stress using a filamentous bio-nanoparticle. Nano Research. 8: 3307-3315. PMID 27570611 DOI: 10.1007/S12274-015-0831-X |
0.779 |
|
| 2015 |
Bunni J, Shelley-Fraser G, Stevenson K, Oltean S, Salmon A, Harper SJ, Carter JG, Bates DO. Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratios. American Journal of Cancer Research. 5: 2083-9. PMID 26269767 |
0.822 |
|
| 2015 |
Hulse RP, Beazley-Long N, Ved N, Bestall SM, Riaz H, Singhal P, Ballmer Hofer K, Harper SJ, Bates DO, Donaldson LF. Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration. Clinical Science (London, England : 1979). 129: 741-56. PMID 26201024 DOI: 10.1042/Cs20150124 |
0.831 |
|
| 2015 |
Wu WK, Georgiadis A, Copland DA, Liyanage S, Luhmann UF, Robbie SJ, Liu J, Wu J, Bainbridge JW, Bates DO, Ali RR, Nicholson LB, Dick AD. IL-4 regulates specific Arg-1(+) macrophage sFlt-1-mediated inhibition of angiogenesis. The American Journal of Pathology. 185: 2324-35. PMID 26079814 DOI: 10.1016/J.Ajpath.2015.04.013 |
0.364 |
|
| 2015 |
de Brot S, Ntekim A, Cardenas R, James V, Allegrucci C, Heery DM, Bates DO, Ødum N, Persson JL, Mongan NP. Regulation of vascular endothelial growth factor in prostate cancer. Endocrine-Related Cancer. 22: R107-23. PMID 25870249 DOI: 10.1530/Erc-15-0123 |
0.432 |
|
| 2015 |
Beazley-Long N, Gaston K, Harper SJ, Orlando A, Bates DO. Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression. American Journal of Cancer Research. 5: 433-41. PMID 25628951 |
0.849 |
|
| 2015 |
Carter JG, Gammons MV, Damodaran G, Churchill AJ, Harper SJ, Bates DO. The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy. Angiogenesis. 18: 23-30. PMID 25274272 DOI: 10.1007/S10456-014-9444-3 |
0.849 |
|
| 2015 |
Hamdollah Zadeh MA, Amin EM, Hoareau-Aveilla C, Domingo E, Symonds KE, Ye X, Heesom KJ, Salmon A, D'Silva O, Betteridge KB, Williams AC, Kerr DJ, Salmon AH, Oltean S, Midgley RS, ... ... Bates DO, et al. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Molecular Oncology. 9: 167-78. PMID 25224594 DOI: 10.1016/J.Molonc.2014.07.017 |
0.839 |
|
| 2015 |
Batson J, Oltean S, Bates D. Targeting the angiogenic 'splice' switch; inhibition of SRPK1 as a novel therapeutic approach in prostate cancer Cancer Cell & Microenvironment. 2. DOI: 10.14800/Ccm.876 |
0.521 |
|
| 2015 |
Star E, Harper S, Bates D, Oltean S. Abstract A14: Use of VEGF-based splicing-sensitive fluorescent reporters to screen for anti-angiogenic molecules Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Tumang15-A14 |
0.78 |
|
| 2015 |
Barratt S, Blythe T, Jarrett C, Ourradi K, Welsh G, Scotton C, Bates D, Millar A. S64 Alveolar epithelial type II cell expression of VEGF-Axxxa is critical for development of Idiopathic Pulmonary Fibrosis (IPF): an anti-fibrotic role for VEGF-Axxxb anti-angiogenic isoforms? Thorax. 70: A38.2-A39. DOI: 10.1136/Thoraxjnl-2015-207770.70 |
0.752 |
|
| 2015 |
Rowlinson J, Batson J, Toop H, Allen C, Gibbons B, Babaei-Jadidi R, Zhang J, Wearmouth S, Knapp S, Morris J, Bates D. Novel SRPK1 inhibitors specifically target alternative splicing in human primary retinal epithelial cells Acta Ophthalmologica. 93: n/a-n/a. DOI: 10.1111/J.1755-3768.2015.0625 |
0.494 |
|
| 2015 |
Blackley Z, Ved N, Schlosser A, Holmskov U, Bates D, Sorensen G. Inhibition of micro-fibrillar associated protein 4 as a potential therapy targeting choroidal neovascularisation in age related macular degeneration Acta Ophthalmologica. 93: n/a-n/a. DOI: 10.1111/J.1755-3768.2015.0377 |
0.782 |
|
| 2015 |
Betteridge K, Arkill K, Neal C, Bates D, Salmon A. Simultaneous Determination of Microvascular Endothelial Glycocalyx Structure and Albumin Flux in vivo The Faseb Journal. 29. DOI: 10.1096/Fasebj.29.1_Supplement.Lb552 |
0.822 |
|
| 2014 |
Oltean S, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Kaura A, Arkill KP, Harris K, Symonds C, Lacey K, Wijeyaratne L, Gammons M, Wylie E, Hulse RP, ... ... Bates DO, et al. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy. Journal of the American Society of Nephrology : Jasn. PMID 25542969 DOI: 10.1681/Asn.2014040350 |
0.827 |
|
| 2014 |
Mavrou A, Brakspear K, Hamdollah-Zadeh M, Damodaran G, Babaei-Jadidi R, Oxley J, Gillatt DA, Ladomery MR, Harper SJ, Bates DO, Oltean S. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene. PMID 25381816 DOI: 10.1038/Onc.2014.360 |
0.843 |
|
| 2014 |
Kikuchi R, Nakamura K, MacLauchlan S, Ngo DT, Shimizu I, Fuster JJ, Katanasaka Y, Yoshida S, Qiu Y, Yamaguchi TP, Matsushita T, Murohara T, Gokce N, Bates DO, Hamburg NM, et al. An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nature Medicine. 20: 1464-71. PMID 25362254 DOI: 10.1038/Nm.3703 |
0.554 |
|
| 2014 |
Hulse RP, Beazley-Long N, Hua J, Kennedy H, Prager J, Bevan H, Qiu Y, Fernandes ES, Gammons MV, Ballmer-Hofer K, Gittenberger de Groot AC, Churchill AJ, Harper SJ, Brain SD, Bates DO, et al. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiology of Disease. 71: 245-59. PMID 25151644 DOI: 10.1016/J.Nbd.2014.08.012 |
0.859 |
|
| 2014 |
Bills VL, Hamdollah-Zadeh M, Soothill PW, Harper SJ, Bates DO. The role of VEGF-A165b in trophoblast survival. Bmc Pregnancy and Childbirth. 14: 278. PMID 25128406 DOI: 10.1186/1471-2393-14-278 |
0.849 |
|
| 2014 |
Ngo DT, Farb MG, Kikuchi R, Karki S, Tiwari S, Bigornia SJ, Bates DO, LaValley MP, Hamburg NM, Vita JA, Hess DT, Walsh K, Gokce N. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation. 130: 1072-80. PMID 25116954 DOI: 10.1161/Circulationaha.113.008171 |
0.498 |
|
| 2014 |
Gammons MV, Lucas R, Dean R, Coupland SE, Oltean S, Bates DO. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma. British Journal of Cancer. 111: 477-85. PMID 25010863 DOI: 10.1038/Bjc.2014.342 |
0.801 |
|
| 2014 |
Thichanpiang P, Harper SJ, Wongprasert K, Bates DO. TNF-α-induced ICAM-1 expression and monocyte adhesion in human RPE cells is mediated in part through autocrine VEGF stimulation. Molecular Vision. 20: 781-9. PMID 24940033 |
0.75 |
|
| 2014 |
Arkill KP, Qvortrup K, Starborg T, Mantell JM, Knupp C, Michel CC, Harper SJ, Salmon AH, Squire JM, Bates DO, Neal CR. Resolution of the three dimensional structure of components of the glomerular filtration barrier. Bmc Nephrology. 15: 24. PMID 24484633 DOI: 10.1186/1471-2369-15-24 |
0.798 |
|
| 2014 |
Barratt S, Blythe T, Jarrett C, Welsh G, Ourradi K, Scotton C, Bates D, Millar A. S137 Vascular Endothelial Growth Factor (vegf) Expression In The Ipf Lung – A Role For Anti-angiogenic Isoforms? Thorax. 69. DOI: 10.1136/Thoraxjnl-2014-206260.143 |
0.748 |
|
| 2014 |
Bills V, Soothill P, Bates D. The role of VEGF165b in trophoblast survival – Implications for pre-eclampsia pathophysiology Placenta. 35: A73. DOI: 10.1016/J.Placenta.2014.06.237 |
0.75 |
|
| 2013 |
Bates DO, Mavrou A, Qiu Y, Carter JG, Hamdollah-Zadeh M, Barratt S, Gammons MV, Millar AB, Salmon AH, Oltean S, Harper SJ. Detection of VEGF-A(xxx)b isoforms in human tissues. Plos One. 8: e68399. PMID 23935865 DOI: 10.1371/Journal.Pone.0068399 |
0.846 |
|
| 2013 |
Gammons MV, Fedorov O, Ivison D, Du C, Clark T, Hopkins C, Hagiwara M, Dick AD, Cox R, Harper SJ, Hancox JC, Knapp S, Bates DO. Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD. Investigative Ophthalmology & Visual Science. 54: 6052-62. PMID 23887803 DOI: 10.1167/Iovs.13-12422 |
0.845 |
|
| 2013 |
Beazley-Long N, Hua J, Jehle T, Hulse RP, Dersch R, Lehrling C, Bevan H, Qiu Y, Lagrèze WA, Wynick D, Churchill AJ, Kehoe P, Harper SJ, Bates DO, Donaldson LF. VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. The American Journal of Pathology. 183: 918-29. PMID 23838428 DOI: 10.1016/J.Ajpath.2013.05.031 |
0.852 |
|
| 2013 |
Gammons MV, Dick AD, Harper SJ, Bates DO. SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity. Investigative Ophthalmology & Visual Science. 54: 5797-806. PMID 23761094 DOI: 10.1167/Iovs.13-11634 |
0.848 |
|
| 2013 |
Delcombel R, Janssen L, Vassy R, Gammons M, Haddad O, Richard B, Letourneur D, Bates D, Hendricks C, Waltenberger J, Starzec A, Sounni NE, Noël A, Deroanne C, Lambert C, et al. New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis. 16: 353-71. PMID 23254820 DOI: 10.1007/S10456-012-9320-Y |
0.795 |
|
| 2013 |
Barratt S, Blythe T, Jarrett C, Ourradi K, Maher T, Welsh G, Bates D, Millar A. P141 Differential expression of conventional and inhibitory VEGFA isoforms in normal and fibrotic fibroblasts–a potential role in IPF pathogenesis? Thorax. 68: A139.2-A140. DOI: 10.1136/Thoraxjnl-2013-204457.291 |
0.757 |
|
| 2013 |
Bills V, Bates D, Soothill P, Overton T. PM.22 The Role of VEGF165B in Trophoblast Survival – Implications For Pre-Eclampsia Pathophysiology Archives of Disease in Childhood - Fetal and Neonatal Edition. 98: A31.3-A32. DOI: 10.1136/Archdischild-2013-303966.106 |
0.824 |
|
| 2012 |
Bates DO, Catalano PJ, Symonds KE, Varey AH, Ramani P, O'Dwyer PJ, Giantonio BJ, Meropol NJ, Benson AB, Harper SJ. Predictive value of the antiangiogenic VEGF splice variant expression for bevacizumab efficacy in the phase III trial of bevacizumab and FOLFOX4 versus FOLFOX4 in previously treated patients with advanced colorectal cancer (ECOG E3200T2). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 545. PMID 27983263 DOI: 10.1200/Jco.2012.30.4_Suppl.545 |
0.744 |
|
| 2012 |
Bates DO, Catalano PJ, Symonds KE, Varey AH, Ramani P, O'Dwyer PJ, Giantonio BJ, Meropol NJ, Benson AB, Harper SJ. Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6384-91. PMID 23104894 DOI: 10.1158/1078-0432.Ccr-12-2223 |
0.829 |
|
| 2012 |
Oltean S, Gammons M, Hulse R, Hamdollah-Zadeh M, Mavrou A, Donaldson L, Salmon AH, Harper SJ, Ladomery MR, Bates DO. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. Biochemical Society Transactions. 40: 831-5. PMID 22817743 DOI: 10.1042/Bst20120051 |
0.836 |
|
| 2012 |
Oltean S, Neal CR, Mavrou A, Patel P, Ahad T, Alsop C, Lee T, Sison K, Qiu Y, Harper SJ, Bates DO, Salmon AH. VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice. American Journal of Physiology. Renal Physiology. 303: F1026-36. PMID 22811490 DOI: 10.1152/Ajprenal.00410.2011 |
0.861 |
|
| 2012 |
Salmon AH, Ferguson JK, Burford JL, Gevorgyan H, Nakano D, Harper SJ, Bates DO, Peti-Peterdi J. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. Journal of the American Society of Nephrology : Jasn. 23: 1339-50. PMID 22797190 DOI: 10.1681/Asn.2012010017 |
0.824 |
|
| 2012 |
Qiu Y, Seager M, Osman A, Castle-Miller J, Bevan H, Tortonese DJ, Murphy D, Harper SJ, Fraser HM, Donaldson LF, Bates DO. Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility. Reproduction (Cambridge, England). 143: 501-11. PMID 22232745 DOI: 10.1530/Rep-11-0091 |
0.846 |
|
| 2012 |
Barratt S, Jarrett C, Blythe T, Welsh G, Maher T, Bates D, Millar A. S68 Bioavailability of VEGF in Idiopathic Pulmonary Fibrosis Thorax. 67: A34.2-A34. DOI: 10.1136/Thoraxjnl-2012-202678.074 |
0.755 |
|
| 2011 |
Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, Nowak DG, Dixon N, Micklefield J, Spannhoff A, Bedford MT, Gregory MA, Martin CJ, Leadlay PF, Zhang MQ, Harper SJ, ... Bates DO, et al. Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science (Royal Society of Chemistry : 2010). 2011: 273-278. PMID 22822423 DOI: 10.1039/C0Sc00297F |
0.859 |
|
| 2011 |
Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, Welsh GI, Cheung MK, Ni L, Kase S, Rennel ES, Symonds KE, Nowak DG, Royer-Pokora B, Saleem MA, Hagiwara M, ... ... Bates DO, et al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell. 20: 768-80. PMID 22172722 DOI: 10.1016/J.Ccr.2011.10.016 |
0.842 |
|
| 2011 |
Bates DO. An unexpected tail of VEGF and PlGF in pre-eclampsia. Biochemical Society Transactions. 39: 1576-82. PMID 22103490 DOI: 10.1042/Bst20110671 |
0.552 |
|
| 2011 |
Rennel ES, Regula JT, Harper SJ, Thomas M, Klein C, Bates DO. A human neutralizing antibody specific to Ang-2 inhibits ocular angiogenesis. Microcirculation (New York, N.Y. : 1994). 18: 598-607. PMID 21851472 DOI: 10.1111/J.1549-8719.2011.00120.X |
0.758 |
|
| 2011 |
Bills VL, Salmon AH, Harper SJ, Overton TG, Neal CR, Jeffery B, Soothill PW, Bates DO. Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre-eclampsia Bjog: An International Journal of Obstetrics and Gynaecology. 118: 1253-1261. PMID 21668772 DOI: 10.1111/J.1471-0528.2011.02925.X |
0.84 |
|
| 2011 |
Carter JG, Cherry J, Williams K, Turner S, Bates DO, Churchill AJ. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease. Current Eye Research. 36: 328-35. PMID 21309690 DOI: 10.3109/02713683.2010.548892 |
0.696 |
|
| 2011 |
Emmett MS, Lanati S, Dunn DB, Stone OA, Bates DO. CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation (New York, N.Y. : 1994). 18: 172-82. PMID 21166932 DOI: 10.1111/J.1549-8719.2010.00074.X |
0.812 |
|
| 2010 |
Harper SJ, Bates DO. Glomerular filtration barrier and molecular segregation: guilty as charged? Journal of the American Society of Nephrology : Jasn. 21: 2009-11. PMID 21071522 DOI: 10.1681/Asn.2010101071 |
0.666 |
|
| 2010 |
Lanati S, Dunn DB, Roussigné M, Emmett MS, Carriere V, Jullien D, Budge J, Fryer J, Erard M, Cailler F, Girard JP, Bates DO. Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo. Cancer Research. 70: 8138-48. PMID 20736366 DOI: 10.1158/0008-5472.Can-10-0175 |
0.801 |
|
| 2010 |
Wu WK, Llewellyn OP, Bates DO, Nicholson LB, Dick AD. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology. 215: 796-803. PMID 20692534 DOI: 10.1016/J.Imbio.2010.05.025 |
0.395 |
|
| 2010 |
Qiu Y, Ferguson J, Oltean S, Neal CR, Kaura A, Bevan H, Wood E, Sage LM, Lanati S, Nowak DG, Salmon AH, Bates D, Harper SJ. Overexpression of VEGF165b in podocytes reduces glomerular permeability. Journal of the American Society of Nephrology : Jasn. 21: 1498-509. PMID 20688932 DOI: 10.1681/Asn.2009060617 |
0.833 |
|
| 2010 |
Foster RR, Welsh GI, Satchell SC, Marlow RD, Wherlock MD, Pons D, Mathieson PW, Bates DO, Saleem MA. Functional distinctions in cytosolic calcium regulation between cells of the glomerular filtration barrier. Cell Calcium. 48: 44-53. PMID 20674014 DOI: 10.1016/J.Ceca.2010.06.005 |
0.581 |
|
| 2010 |
Peiris-Pagès M, Harper SJ, Bates DO, Ramani P. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth. The Journal of Pathology. 222: 138-47. PMID 20662003 DOI: 10.1002/Path.2746 |
0.873 |
|
| 2010 |
Emmett MS, Symonds KE, Rigby H, Cook MG, Price R, Metcalfe C, Orlando A, Bates DO. Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. Bmc Cancer. 10: 208. PMID 20478045 DOI: 10.1186/1471-2407-10-208 |
0.773 |
|
| 2010 |
Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovascular Research. 87: 262-71. PMID 20400620 DOI: 10.1093/Cvr/Cvq105 |
0.554 |
|
| 2010 |
Cristofaro B, Stone OA, Caporali A, Dawbarn D, Ieronimakis N, Reyes M, Madeddu P, Bates DO, Emanueli C. Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1143-50. PMID 20360537 DOI: 10.1161/Atvbaha.109.205468 |
0.779 |
|
| 2010 |
Hua J, Spee C, Kase S, Rennel ES, Magnussen AL, Qiu Y, Varey A, Dhayade S, Churchill AJ, Harper SJ, Bates DO, Hinton DR. Recombinant human VEGF165b inhibits experimental choroidal neovascularization. Investigative Ophthalmology & Visual Science. 51: 4282-8. PMID 20237252 DOI: 10.1167/Iovs.09-4360 |
0.853 |
|
| 2010 |
Magnussen AL, Rennel ES, Hua J, Bevan HS, Beazley Long N, Lehrling C, Gammons M, Floege J, Harper SJ, Agostini HT, Bates DO, Churchill AJ. VEGF-A165b is cytoprotective and antiangiogenic in the retina. Investigative Ophthalmology & Visual Science. 51: 4273-81. PMID 20237249 DOI: 10.1167/Iovs.09-4296 |
0.853 |
|
| 2010 |
Varet J, Douglas SK, Gilmartin L, Medford AR, Bates DO, Harper SJ, Millar AB. VEGF in the lung: a role for novel isoforms. American Journal of Physiology. Lung Cellular and Molecular Physiology. 298: L768-74. PMID 20228180 DOI: 10.1152/Ajplung.00353.2009 |
0.782 |
|
| 2010 |
Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. The Journal of Biological Chemistry. 285: 5532-40. PMID 19906640 DOI: 10.1074/Jbc.M109.074930 |
0.853 |
|
| 2009 |
Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO. The anti-angiogenic isoforms of VEGF in health and disease. Biochemical Society Transactions. 37: 1207-13. PMID 19909248 DOI: 10.1042/Bst0371207 |
0.815 |
|
| 2009 |
Rennel ES, Varey AH, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. British Journal of Cancer. 101: 1183-93. PMID 19707198 DOI: 10.1038/Sj.Bjc.6605249 |
0.854 |
|
| 2009 |
Woolard J, Bevan HS, Harper SJ, Bates DO. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation (New York, N.Y. : 1994). 16: 572-92. PMID 19521900 DOI: 10.1080/10739680902997333 |
0.87 |
|
| 2009 |
Rennel ES, Harper SJ, Bates DO. Therapeutic potential of manipulating VEGF splice isoforms in oncology. Future Oncology (London, England). 5: 703-12. PMID 19519209 DOI: 10.2217/Fon.09.33 |
0.793 |
|
| 2009 |
Benest AV, Bates DO. Measurement of angiogenic phenotype by use of two-dimensional mesenteric angiogenesis assay. Methods in Molecular Biology (Clifton, N.J.). 467: 251-70. PMID 19301676 DOI: 10.1007/978-1-59745-241-0_15 |
0.811 |
|
| 2009 |
Salmon AHJ, Neal CR, Sage LM, Glass CA, Harper SJ, Bates DO. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx Cardiovascular Research. 83: 24-33. PMID 19297368 DOI: 10.1093/Cvr/Cvp093 |
0.833 |
|
| 2009 |
Foster RR, Zadeh MA, Welsh GI, Satchell SC, Ye Y, Mathieson PW, Bates DO, Saleem MA. Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells. Cell Calcium. 45: 384-90. PMID 19232718 DOI: 10.1016/J.Ceca.2009.01.003 |
0.579 |
|
| 2009 |
Stone OA, Richer C, Emanueli C, van Weel V, Quax PH, Katare R, Kraenkel N, Campagnolo P, Barcelos LS, Siragusa M, Sala-Newby GB, Baldessari D, Mione M, Vincent MP, Benest AV, ... ... Bates DO, et al. Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 657-64. PMID 19164804 DOI: 10.1161/Atvbaha.108.182139 |
0.792 |
|
| 2009 |
Bills VL, Varet J, Millar A, Harper SJ, Soothill PW, Bates DO. Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clinical Science (London, England : 1979). 116: 265-72. PMID 18826376 DOI: 10.1042/Cs20080270 |
0.825 |
|
| 2009 |
Augello A, Vergani A, Jurewicz M, Dada S, D'Addio F, Mocci A, Sayegh M, Abdi R, Fiorina P, Zhang Q, Shi Y, Li Y, Zhang Y, Lee V, Zheng D, ... ... Bates DO, et al. Diabetes mellitus - basic research Ndt Plus. 2. DOI: 10.1093/Ndtplus/2.S2.7 |
0.653 |
|
| 2008 |
Bevan HS, Van Den Akker NMS, Qiu Y, Polman JAE, Foster RR, Yem J, Nishikawa A, Satchell SC, Harper SJ, Gittenberger-De Groot AC, Bates DO. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGF xxxb in human kidney development Nephron - Physiology. 110. PMID 19039247 DOI: 10.1159/000177614 |
0.849 |
|
| 2008 |
Harper SJ, Bates DO. VEGF-A splicing: the key to anti-angiogenic therapeutics? Nature Reviews. Cancer. 8: 880-7. PMID 18923433 DOI: 10.1038/Nrc2505 |
0.798 |
|
| 2008 |
Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. Journal of Cell Science. 121: 3487-95. PMID 18843117 DOI: 10.1242/Jcs.016410 |
0.85 |
|
| 2008 |
Hamdollah Zadeh MA, Glass CA, Magnussen A, Hancox JC, Bates DO. VEGF-mediated elevated intracellular calcium and angiogenesis in human microvascular endothelial cells in vitro are inhibited by dominant negative TRPC6. Microcirculation (New York, N.Y. : 1994). 15: 605-14. PMID 18800249 DOI: 10.1080/10739680802220323 |
0.855 |
|
| 2008 |
Foster RR, Slater SC, Seckley J, Kerjaschki D, Bates DO, Mathieson PW, Satchell SC. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium American Journal of Pathology. 173: 938-948. PMID 18772335 DOI: 10.2353/Ajpath.2008.070416 |
0.738 |
|
| 2008 |
Rennel ES, Hamdollah-Zadeh MA, Wheatley ER, Magnussen A, Schüler Y, Kelly SP, Finucane C, Ellison D, Cebe-Suarez S, Ballmer-Hofer K, Mather S, Stewart L, Bates DO, Harper SJ. Recombinant human VEGF165b protein is an effective anti-cancer agent in mice. European Journal of Cancer (Oxford, England : 1990). 44: 1883-94. PMID 18657413 DOI: 10.1016/J.Ejca.2008.05.027 |
0.802 |
|
| 2008 |
Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Research. 68: 4683-92. PMID 18559514 DOI: 10.1158/0008-5472.Can-07-6577 |
0.808 |
|
| 2008 |
Benest AV, Stone OA, Miller WH, Glover CP, Uney JB, Baker AH, Harper SJ, Bates DO. Arteriolar genesis and angiogenesis induced by endothelial nitric oxide synthase overexpression results in a mature vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1462-8. PMID 18497305 DOI: 10.1161/Atvbaha.108.169375 |
0.864 |
|
| 2008 |
Varey AHR, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, Harper SJ, Bates DO. VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: Balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy British Journal of Cancer. 98: 1366-1379. PMID 18349829 DOI: 10.1038/Sj.Bjc.6604308 |
0.85 |
|
| 2008 |
Rennel E, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman E, Bates D, Harper S. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. British Journal of Cancer. 98: 1250-7. PMID 18349828 DOI: 10.1038/Sj.Bjc.6604309 |
0.792 |
|
| 2008 |
Gopi SS, Hamdollah-Zadeh M, Harper SJ, Bates DO, Gillatt DA. Expression of anti-angiogenic isoform, VEGF(165)b in transitional cell carcinoma of bladder Bjui. 101: 29-30. PMID 18251944 DOI: 10.1111/J.1464-410X.2007.07400.X |
0.446 |
|
| 2008 |
Benest AV, Harper SJ, Herttuala SY, Alitalo K, Bates DO. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis Cardiovascular Research. 78: 315-323. PMID 18065770 DOI: 10.1093/Cvr/Cvm094 |
0.853 |
|
| 2008 |
Qiu Y, Bevan H, Weeraperuma S, Wratting D, Murphy D, Neal CR, Bates DO, Harper SJ. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b Faseb Journal. 22: 1104-1112. PMID 18032632 DOI: 10.1096/Fj.07-9718Com |
0.844 |
|
| 2008 |
Bevan HS, Akker NMSvd, Qiu Y, Polman JAE, Foster RR, Yem J, Nishikawa A, Satchell SC, Harper SJ, Groot ACG, Bates DO. Contents Vol. 110, 2008 Nephron Physiology. 110. DOI: 10.1159/000187120 |
0.751 |
|
| 2008 |
Gopi SS, Zadeh MH, Sen C, Harper SJ, Bates DO, Gillatt DA. INVIVO EXPRESSION OF VEGF
165
b, AN INHIBITORY SPLICE VARIANT OF VEGF165 IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER Journal of Urology. 179: 316-316. DOI: 10.1016/S0022-5347(08)60925-8 |
0.771 |
|
| 2008 |
Gopi S, H-Zadeh M, Sen C, Harper S, Bates D, Gillatt D. SCHU-01: VEGF165b, an Inhibitory Splice Variant of VEGF165 in Transitional Cell Carcinoma of the Bladder: In Vivo Expression Urology. 72: S3. DOI: 10.1016/J.Urology.2008.08.004 |
0.738 |
|
| 2007 |
Perrin RM, Harper SJ, Bates DO. A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus Cell Biochemistry and Biophysics. 49: 65-72. PMID 17906361 DOI: 10.1007/S12013-007-0041-6 |
0.799 |
|
| 2007 |
Perrin RM, Harper SJ, Corrall R, Bates DO. Hyperglycemia stimulates a sustained increase in hydraulic conductivity in vivo without any change in reflection coefficient Microcirculation. 14: 683-696. PMID 17885994 DOI: 10.1080/10739680701436129 |
0.78 |
|
| 2007 |
Salmon AH, Toma I, Sipos A, Muston PR, Harper SJ, Bates DO, Neal CR, Peti-Peterdi J. Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space. American Journal of Physiology. Renal Physiology. 293: F1777-86. PMID 17804486 DOI: 10.1152/Ajprenal.00187.2007 |
0.768 |
|
| 2007 |
Neal CR, Muston PR, Njegovan D, Verrill R, Harper SJ, Deen WM, Bates DO. Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditions. American Journal of Physiology. Renal Physiology. 293: F1787-98. PMID 17715264 DOI: 10.1152/Ajprenal.00157.2007 |
0.662 |
|
| 2007 |
Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, Harper SJ, Bates DO. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. British Journal of Cancer. 97: 223-30. PMID 17595666 DOI: 10.1038/sj.bjc.6603839 |
0.844 |
|
| 2007 |
Cross SE, Richards SK, Clark A, Benest AV, Bates DO, Mathieson PW, Johnson PR, Harper SJ, Smith RM. Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs. Diabetologia. 50: 1423-32. PMID 17476476 DOI: 10.1007/S00125-007-0670-8 |
0.859 |
|
| 2007 |
Shields JD, Emmett MS, Dunn DB, Joory KD, Sage LM, Rigby H, Mortimer PS, Orlando A, Levick JR, Bates DO. Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene. 26: 2997-3005. PMID 17130836 DOI: 10.1038/Sj.Onc.1210114 |
0.792 |
|
| 2007 |
Ladomery MR, Harper SJ, Bates DO. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Letters. 249: 133-42. PMID 17027147 DOI: 10.1016/J.Canlet.2006.08.015 |
0.865 |
|
| 2007 |
Salmon A, Toma I, Harper S, Bates D, Neal C, Peti‐Peterdi J. Multiphoton imaging of sub‐podocyte space in isolated perfused glomeruli The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A503-A |
0.755 |
|
| 2007 |
Nowak DG, Amin E, Ladomery MR, Harper SJ, Bates DO. Selective upregulation of anti‐angiogenic splice variants of VEGF by TGF‐β1 is mediated by Cdc2‐like kinase family (Clk) and p38 MAPK The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A248-D |
0.806 |
|
| 2007 |
Gopi S, Zadeh M, Harper S, Bates D, Gillatt D. MP-04.12: Anti angiogenic VEGF165b is an inhibitory splice variant of VEGF in transitional cell carcinoma of the bladder Urology. 70: 61. DOI: 10.1016/J.Urology.2007.06.241 |
0.74 |
|
| 2006 |
Benest AV, Salmon AH, Wang W, Glover CP, Uney J, Harper SJ, Bates DO. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue Microcirculation. 13: 423-437. PMID 16864410 DOI: 10.1080/10739680600775940 |
0.856 |
|
| 2006 |
Joory KD, Levick JR, Mortimer PS, Bates DO. Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. Lymphatic Research and Biology. 4: 73-82. PMID 16808669 DOI: 10.1089/Lrb.2006.4.73 |
0.846 |
|
| 2006 |
Cheng HW, James AF, Foster RR, Hancox JC, Bates DO. VEGF activates receptor-operated cation channels in human microvascular endothelial cells Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1768-1776. PMID 16763162 DOI: 10.1161/01.Atv.0000231518.86795.0F |
0.713 |
|
| 2006 |
Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Molecular Vision. 12: 626-32. PMID 16735996 |
0.446 |
|
| 2006 |
Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, Saleem MA, Mathieson PW, Bates DO, Harper SJ. VEGF-C promotes survival in podocytes American Journal of Physiology - Renal Physiology. 291. PMID 16525158 DOI: 10.1152/Ajprenal.00431.2005 |
0.848 |
|
| 2006 |
Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO, Christofori G, Augustin HG. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors American Journal of Pathology. 168: 1045-1053. PMID 16507917 DOI: 10.2353/Ajpath.2006.050554 |
0.787 |
|
| 2006 |
Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clinical Science (London, England : 1979). 110: 575-85. PMID 16451124 DOI: 10.1042/Cs20050292 |
0.854 |
|
| 2006 |
Glass CA, Harper SJ, Bates DO. The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo. The Journal of Physiology. 572: 243-57. PMID 16423853 DOI: 10.1113/Jphysiol.2005.103127 |
0.865 |
|
| 2006 |
Glass CA, Perrin RM, Pocock TM, Bates DO. Transient osmotic absorption of fluid in microvessels exposed to low concentrations of dimethyl sulfoxide Microcirculation. 13: 29-40. PMID 16393944 DOI: 10.1080/10739680500383464 |
0.782 |
|
| 2006 |
Salmon AHJ, Neal CR, Bates DO, Harper SJ. Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli Journal of Physiology. 570: 141-156. PMID 16239266 DOI: 10.1113/Jphysiol.2005.099184 |
0.781 |
|
| 2006 |
Dunn D, Pritchard-Jones R, Qui Y, Rigby H, Orlando A, Harper S, Bates D. VEGF-A isoform ratios are altered in metastasis in primary malignant melanoma Melanoma Research. 16: S50-S51. DOI: 10.1097/00008390-200609001-00090 |
0.332 |
|
| 2006 |
Emmett M, Dunn D, Bates D. Lymphatic secreted chemokines mediate migration of melanoma cell lines Melanoma Research. 16: S12. DOI: 10.1097/00008390-200609001-00019 |
0.775 |
|
| 2006 |
Alalwany R, Bates DO, Morgan K, Donaldson LF. P2-163: NEUROPROTECTIVE EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MODEL OF β-AMYLOID INDUCED NEUROTOXICITY Alzheimer's & Dementia. 14: P731-P731. DOI: 10.1016/J.Jalz.2018.06.850 |
0.798 |
|
| 2005 |
Bates DO, Harper SJ. Therapeutic potential of inhibitory VEGF splice variants. Future Oncology (London, England). 1: 467-73. PMID 16556023 DOI: 10.2217/14796694.1.4.467 |
0.781 |
|
| 2005 |
Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor Diabetologia. 48: 2422-2427. PMID 16193288 DOI: 10.1007/S00125-005-1951-8 |
0.86 |
|
| 2005 |
Neal CR, Crook H, Bell E, Harper SJ, Bates DO. Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space Journal of the American Society of Nephrology. 16: 1223-1235. PMID 15829713 DOI: 10.1681/Asn.2004100822 |
0.658 |
|
| 2005 |
Glass CA, Pocock TM, Curry FE, Bates DO. Cytosolic Ca2+ concentration and rate of increase of the cytosolic Ca2+ concentration in the regulation of vascular permeability in Rana in vivo. The Journal of Physiology. 564: 817-27. PMID 15718259 DOI: 10.1113/Jphysiol.2005.083220 |
0.77 |
|
| 2005 |
Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes. Journal of the American Society of Nephrology : Jasn. 16: 629-37. PMID 15659563 DOI: 10.1681/Asn.2004030172 |
0.749 |
|
| 2005 |
Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes American Journal of Physiology - Renal Physiology. 288. PMID 15339792 DOI: 10.1152/Ajprenal.00146.2004 |
0.839 |
|
| 2004 |
Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, ... ... Bates DO, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Research. 64: 7822-35. PMID 15520188 DOI: 10.1158/0008-5472.Can-04-0934 |
0.866 |
|
| 2004 |
Wang WY, Whittles CE, Harper SJ, Bates DO. An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery. Microcirculation (New York, N.Y. : 1994). 11: 361-75. PMID 15280075 DOI: 10.1080/10739680490437568 |
0.794 |
|
| 2004 |
Neal CR, Hunter AJ, Harper SJ, Soothill PW, Bates DO. Plasma from women with severe pre-eclampsia increases microvascular permeability in an animal model in vivo Clinical Science. 107: 399-405. PMID 15186215 DOI: 10.1042/Cs20040018 |
0.709 |
|
| 2004 |
Glass CA, Bates DO. The role of endothelial cell Ca2+ store release in the regulation of microvascular permeability in vivo. Experimental Physiology. 89: 343-51. PMID 15123553 DOI: 10.1113/Expphysiol.2003.026948 |
0.786 |
|
| 2004 |
Shields JD, Borsetti M, Rigby H, Harper SJ, Mortimer PS, Levick JR, Orlando A, Bates DO. Lymphatic density and metastatic spread in human malignant melanoma. British Journal of Cancer. 90: 693-700. PMID 14760386 DOI: 10.1038/Sj.Bjc.6601571 |
0.781 |
|
| 2004 |
Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, Harper SJ. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein American Journal of Physiology - Renal Physiology. 286. PMID 14644752 DOI: 10.1152/Ajprenal.00337.2003 |
0.854 |
|
| 2004 |
Pocock TM, Foster RR, Bates DO. Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo American Journal of Physiology - Heart and Circulatory Physiology. 286. PMID 14551041 DOI: 10.1152/Ajpheart.00826.2003 |
0.72 |
|
| 2004 |
Salmon AHJ, Bates DO, Harper SJ. PC35 THE ULTRAFILTRATION COEFFICIENT (LpA) OF MAMMALIAN GLOMERULI DOES NOT DISPLAY RECTIFICATION Microcirculation. 11: 550-551. DOI: 10.1080/10739680490488742 |
0.62 |
|
| 2004 |
Qiu Y, Perrin RM, Woolard J, Cui T-, Mushens R, Harper SJ, Bates DO. PC34 ANTIBODIES SPECIFIC TO THE C TERMINUS OF VEGF165b, DETECT PROTEIN IN NORMAL HUMAN PLASMA Microcirculation. 11: 550-550. DOI: 10.1080/10739680490488733 |
0.765 |
|
| 2004 |
Neal CR, Bell E, Crook H, Bates DO, Harper SJ. PC33 3D RECONSTRUCTION OF THE GLOMERULAR CAPILLARY TUFT SHOWS A SECOND RESTRICTIVE SPACE BETWEEN THE GLOMERULAR FILTRATION BARRIER (GFB) AND PERIPHERAL BOWMAN'S SPACE Microcirculation. 11: 550-550. DOI: 10.1080/10739680490488724 |
0.622 |
|
| 2004 |
Foster RR, Mathieson PW, Saleem MA, Bates DO, Harper SJ. PC32 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ACTS THROUGH NEPHRIN TO REDUCE APOPTOSIS IN HUMAN CONDITIONALLY IMMORTALISED PODOCYTES (HCIPS) Microcirculation. 11: 549-550. DOI: 10.1080/10739680490488715 |
0.838 |
|
| 2004 |
Bevan HS, Qiu Y, Foster R, Digby-Bell J, Harper SJ, Bates DO. PC31 EXPRESSION OF THE INHIBITORY VEGF ISOFORM VEGF 165b IN HUMAN KIDNEY Microcirculation. 11: 549-549. DOI: 10.1080/10739680490488706 |
0.828 |
|
| 2004 |
Joory KD, Shields JD, Levick JR, Mortimer PS, Bates DO. PC18 PERITUMOUR LYMPHATIC DENSITY (LD) IN METASTATIC MALIGNANT MELANOMA LIES WITHIN THE RANGE OF SUPERFICIAL DERMAL LD IN NORMAL HUMAN SKIN Microcirculation. 11: 544-545. DOI: 10.1080/10739680490488571 |
0.763 |
|
| 2004 |
Benest AV, Harper SJ, Bates DO. PC1 MEASUREMENT OF BLOOD FLOW USING A NON-RADIOACTIVE CLEARANCE TECHNIQUE IN RAT MESENTERIC TISSUE [moor instruments award] Microcirculation. 11: 539-539. DOI: 10.1080/10739680490488409 |
0.767 |
|
| 2004 |
Neal CR, Crook H, Bell E, Bates DO, Harper SJ. OC25 RECONSTRUCTION OF THE SUB-PODOCYTE SPACE (SPS) REVEALS SIGNIFICANT PATHLENGTH AND RESTRICTION TO FLUID FLOW IN THE REMAINDER OF BOWMAN'S SPACE Microcirculation. 11: 537-537. DOI: 10.1080/10739680490488355 |
0.614 |
|
| 2004 |
Wang W-, Whittles CE, Harper SJ, Bates DO. OC22 CHARACTERISATION OF FILOPODIA OF ENDOTHELIAL SPROUT TIP CELLS IN RAT MESENTERIC ANGIOGENESIS Microcirculation. 11: 536-536. DOI: 10.1080/10739680490488328 |
0.806 |
|
| 2004 |
Bevan HS, Woolard J, Harper SJ, Bates DO. OC21 VEGF165b INHIBITS VEGF165 MEDIATED VEGF-R2 PHOSPHORYLATION AND AKT PHOSPHORYLATION Microcirculation. 11: 536-536. DOI: 10.1080/10739680490488319 |
0.831 |
|
| 2004 |
Joory KD, Levick JR, Mortimer PS, Bates DO. OC15 LYMPHATIC VESSEL DISTRIBUTION IN HUMAN SKIN Microcirculation. 11: 534-534. DOI: 10.1080/10739680490488256 |
0.776 |
|
| 2004 |
Shields JD, Mortimer PS, Levick JR, Bates DO. OC13 A COMPARISON OF LYMPHATIC VESSEL DENSITIES BETWEEN DIFFERENT LYMPHATIC SPECIFIC MARKERS Microcirculation. 11: 533-533. DOI: 10.1080/10739680490488238 |
0.796 |
|
| 2004 |
Jones ROP, Shields JD, Woolard J, Harper SJ, Bates DO. OC11 DIFFERENTIAL VEGF ISOFORM EXPRESSION REGULATES GROWTH OF XENOGRAFTED MALIGNANT MELANOMA [terence Ryan award] Microcirculation. 11: 532-533. DOI: 10.1080/10739680490488210 |
0.831 |
|
| 2003 |
Bates DO, Jones RO. The role of vascular endothelial growth factor in wound healing. The International Journal of Lower Extremity Wounds. 2: 107-20. PMID 15866835 DOI: 10.1177/1534734603256626 |
0.539 |
|
| 2003 |
Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascular Pharmacology. 39: 225-37. PMID 12747962 DOI: 10.1016/S1537-1891(03)00011-9 |
0.804 |
|
| 2003 |
Harper SJ, Bates DO. Endothelial permeability in uremia. Kidney International. Supplement. S41-4. PMID 12694306 DOI: 10.1046/J.1523-1755.63.S84.15.X |
0.765 |
|
| 2003 |
Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes American Journal of Physiology - Renal Physiology. 284. PMID 12620928 DOI: 10.1152/Ajprenal.00276.2002 |
0.822 |
|
| 2003 |
Glass CA, Bates DO. Role of endothelial Ca2+ stores in the regulation of hydraulic conductivity of Rana microvessels in vivo. American Journal of Physiology. Heart and Circulatory Physiology. 284: H1468-78. PMID 12511429 DOI: 10.1152/Ajpheart.00585.2002 |
0.773 |
|
| 2003 |
Whittles CE, Pocock TM, Wedge SR, Kendrew J, Hennequin LF, Harper SJ, Bates DO. ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation (New York, N.Y. : 1994). 9: 513-22. PMID 12483548 DOI: 10.1038/Sj.Mn.7800164 |
0.796 |
|
| 2002 |
Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. Regulation of microvascular permeability by vascular endothelial growth factors. Journal of Anatomy. 200: 581-97. PMID 12162726 DOI: 10.1046/J.1469-7580.2002.00066.X |
0.583 |
|
| 2002 |
Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Research. 62: 4123-31. PMID 12124351 |
0.852 |
|
| 2002 |
Harper SJ, Tomson CR, Bates DO. Human uremic plasma increases microvascular permeability to water and proteins in vivo. Kidney International. 61: 1416-22. PMID 11918748 DOI: 10.1046/J.1523-1755.2002.00252.X |
0.673 |
|
| 2002 |
Pocock TM, Bates DO. In vivo mechanisms of vascular endothelial growth factor-mediated increased hydraulic conductivity of Rana capillaries. The Journal of Physiology. 534: 479-88. PMID 11454965 DOI: 10.1111/J.1469-7793.2001.00479.X |
0.466 |
|
| 2001 |
Bates DO, Heald RI, Curry FE, Williams B. Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways. The Journal of Physiology. 533: 263-72. PMID 11351033 DOI: 10.1111/J.1469-7793.2001.0263B.X |
0.687 |
|
| 2001 |
Hillman NJ, Whittles CE, Pocock TM, Williams B, Bates DO. Differential effects of vascular endothelial growth factor-C and placental growth factor-1 on the hydraulic conductivity of frog mesenteric capillaries Journal of Vascular Research. 38: 176-186. PMID 11316953 DOI: 10.1159/000051044 |
0.538 |
|
| 2000 |
Pocock TM, Williams B, Curry FE, Bates DO. VEGF and ATP act by different mechanisms to increase microvascular permeability and endothelial [Ca(2+)](i). American Journal of Physiology. Heart and Circulatory Physiology. 279: H1625-34. PMID 11009449 DOI: 10.1152/Ajpheart.2000.279.4.H1625 |
0.606 |
|
| 1999 |
Bates DO. The chronic effect of vascular endothelial growth factor on individually perfused frog mesenteric microvessels. The Journal of Physiology. 225-33. PMID 9782172 DOI: 10.1111/J.1469-7793.1998.225By.X |
0.493 |
|
| 1999 |
BATES DO, LODWICK D, WILLIAMS B. Vascular Endothelial Growth Factor and Microvascular Permeability Microcirculation. 6: 83-96. DOI: 10.1111/J.1549-8719.1999.Tb00091.X |
0.573 |
|
| 1997 |
Bates DO, Curry FE. Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. The American Journal of Physiology. 273: H687-94. PMID 9277485 DOI: 10.1152/Ajpheart.1997.273.2.H687 |
0.713 |
|
| 1996 |
Bates DO, Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. The American Journal of Physiology. 271: H2520-8. PMID 8997313 DOI: 10.1152/Ajpheart.1996.271.6.H2520 |
0.698 |
|
| 1996 |
Mortimer P, Bates D, Brassington H, Stanton A, Strachan D, Levick J. The prevalence of arm oedema following treatment for breast cancer Qjm. 89: 377-380. DOI: 10.1093/Qjmed/89.5.377 |
0.712 |
|
| 1995 |
Bates DO, Stanton AWB, Levick JR, Mortimer PS. The Effect of Hosiery on Interstitial Fluid Pressure and Arm Volume Fluctuations in Breast Cancer Related Arm Oedema Phlebology: the Journal of Venous Disease. 10: 46-50. DOI: 10.1177/026835559501000203 |
0.713 |
|
| 1994 |
Bates DO, Levick JR, Mortimer PS. Starling pressures in the human arm and their alteration in postmastectomy oedema. The Journal of Physiology. 477: 355-63. PMID 7932226 DOI: 10.1113/Jphysiol.1994.Sp020197 |
0.715 |
|
| 1994 |
Bates DO, Levick JR, Mortimer PS. Quantification of rate and depth of pitting in human edema using an electronic tonometer. Lymphology. 27: 159-72. PMID 7898130 |
0.699 |
|
| 1993 |
Luetolf O, Bull RH, Bates DO, Mortimer PS. Capillary underperfusion in chronic venous insufficiency: a cause for leg ulceration? The British Journal of Dermatology. 128: 249-54. PMID 8471507 DOI: 10.1111/J.1365-2133.1993.Tb00166.X |
0.493 |
|
| 1993 |
Bates DO, Levick JR, Mortimer PS. Change in macromolecular composition of interstitial fluid from swollen arms after breast cancer treatment, and its implications. Clinical Science (London, England : 1979). 85: 737-46. PMID 8287667 DOI: 10.1042/Cs0850737 |
0.72 |
|
| 1992 |
Bull RH, Bates DO, Mortimer PS. Intravital video-capillaroscopy for the study of the microcirculation in psoriasis. The British Journal of Dermatology. 126: 436-45. PMID 1610683 DOI: 10.1111/J.1365-2133.1992.Tb15113.X |
0.495 |
|
| 1992 |
Bates DO, Levick JR, Mortimer PS. Subcutaneous interstitial fluid pressure and arm volume in lymphoedema. International Journal of Microcirculation, Clinical and Experimental / Sponsored by the European Society For Microcirculation. 11: 359-73. PMID 1459796 |
0.699 |
|
| 1992 |
Bates D, Levick J, Mortimer P. Evidence for Microvascular Disturbances in “Postmastectomy Lymphoedema” Clinical Science. 82: 38P-38P. DOI: 10.1042/Cs082038Pb |
0.722 |
|
| Show low-probability matches. |